
RET-IN-17 is a potent inhibitor of RET. RET-IN-17 has the potential for the research of pain associated with IBS and other gastrointestinal disorders and for the research of cancers with constitutive RET kinase activity (extracted from patent WO2016038552A1, compound 1)[1].

V predajniach zdravej výživy a na rôznych internetových stránkach môžete naraziť na kapsuly obsahujú...
Čítať viac